|
Market Closed -
NYSE
04:02:59 2026-11-04 pm EST
|
5-day change | 1st Jan Change | ||
| 379.99 USD | +1.35% |
|
-1.33% | +25.41% |
| Nov. 04 | Bio-Rad Laboratories Q3 Adjusted Earnings, Revenue Rise | MT |
| Nov. 04 | Bio-Rad Laboratories, Inc., Q3 2026 Earnings Call, Nov 04, 2026 |
| Market Cap | 10.16B 9.05B 8.3B 7.54B 14.18B 960B 14.51B 99.21B 39.77B 508B 38.13B 37.31B 1,610B | P/E 2026 * |
45.7x | P/E 2027 * | 44.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.41B 8.38B 7.69B 6.99B 13.14B 889B 13.44B 91.9B 36.84B 471B 35.32B 34.56B 1,491B | EV / Sales 2026 * |
3.66x | EV / Sales 2027 * | 3.5x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Tradegate
| BUWA | Real-time | |
|
Deutsche Boerse AG
| BUWA | Delayed | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Boerse Muenchen
| BUWA | Real-time |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +1.35% | ||
| 1 week | -1.33% | ||
| Current month | +2.10% | ||
| 1 month | +2.94% | ||
| 3 months | +14.15% | ||
| 6 months | +47.36% | ||
| Current year | +25.41% |
| 1 week | 361.26 |  | 384 |
| 1 month | 347.29 | | 390.16 |
| Current year | 236.73 | | 396.23 |
| 1 year | 236.73 | | 396.23 |
| 3 years | 211.43 | | 396.23 |
| 5 years | 211.43 | | 784.39 |
| 10 years | 164.44 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/6/26 | Exercice | General Counsel | 1,841 | 0.0085% | ||
| 9/6/26 | Exercice | Chief Executive Officer | 8,764 | 0.0404% | ||
| 9/6/26 | Exercice | Chief Financial Officer | 3,854 | 0.0178% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.35% | -1.33% | +22.20% | +32.00% | 10.16B | |
| +5.59% | +12.54% | -8.18% | +20.52% | 200B | |
| +6.15% | +10.74% | +16.08% | +44.65% | 128B | |
| +9.37% | +11.73% | -6.33% | +22.96% | 129B | |
| +0.85% | +6.96% | -39.74% | +10.39% | 97.53B | |
| +3.96% | +9.14% | +2.75% | +81.38% | 67.55B | |
| +5.56% | +7.19% | +16.84% | -19.20% | 56.98B | |
| +3.94% | +24.10% | -3.26% | +62.72% | 55.04B | |
| -1.39% | -8.56% | -2.92% | +53.39% | 51.24B | |
| -0.85% | +7.52% | +5.58% | -5.25% | 37.43B | |
| Average | +3.45% | +7.82% | +0.30% | +30.36% | 83.36B | |
| Weighted average by Cap. | +4.69% | +9.65% | -3.61% | +29.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.29B 2.1B 1.91B 3.59B 243B 3.67B 25.1B 10.06B 129B 9.64B 9.44B 407B | 2.62B 2.34B 2.14B 1.95B 3.66B 248B 3.75B 25.63B 10.27B 131B 9.85B 9.64B 416B |
| Net income | 225M 200M 184M 167M 314M 21.25B 321M 2.2B 880M 11.25B 844M 826M 35.63B | 230M 205M 188M 171M 321M 21.71B 328M 2.24B 899M 11.49B 862M 844M 36.4B |
| Net Debt | -749M -667M -612M -556M -1.05B -70.79B -1.07B -7.32B -2.93B -37.47B -2.81B -2.75B -119B | -965M -860M -789M -717M -1.35B -91.24B -1.38B -9.43B -3.78B -48.29B -3.62B -3.55B -153B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-04 | $379.99 | +1.35% | 281,797 |
| 26-11-03 | $374.91 | +2.39% | 214,422 |
| 26-11-02 | $366.16 | -1.62% | 211,833 |
| 26-10-30 | $372.18 | -3.18% | 183,089 |
| 26-10-29 | $384.40 | -0.19% | 332,347 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
